At4g27050 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% ProClin 300
Constituents: 50% Glycerol, 0.01M Phosphate-Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
14-16 weeks lead time (made-to-order)
Synonyms
At4g27050 antibody; F10M23.390F-box protein At4g27050 antibody
Target Names
At4g27050
Uniprot No.

Target Background

Function
This antibody targets At4g27050, a component of SCF (Skp1-Cullin-F-box) E3 ubiquitin ligase complexes. These complexes mediate the ubiquitination and subsequent proteasomal degradation of target proteins.
Database Links

KEGG: ath:AT4G27050

STRING: 3702.AT4G27050.1

UniGene: At.27335

Q&A

What is the At4g27050 gene and what protein does it encode?

At4g27050 is a genomic region in Arabidopsis thaliana associated with extra copies of the ATFOLT1 gene. This gene encodes a folate transporter protein that plays a crucial role in folate homeostasis within plant cells. The protein is involved in cellular metabolism and development processes. Research indicates that this region has particular significance in epigenetic studies, as the presence of extra copies at this locus can influence DNA methylation patterns in hybrid plants and affect gene expression of related sequences . When designing experiments utilizing antibodies against proteins encoded by this region, researchers should consider the specific isoforms and potential cross-reactivity with other folate transporters.

How do I validate the specificity of an At4g27050 antibody?

Validating antibody specificity is critical to ensure reliable research results. For At4g27050 antibodies, consider implementing these methodological approaches:

  • Western blot analysis: Run protein samples from wild-type plants alongside knockout/knockdown mutants of At4g27050. A specific antibody should show decreased or absent signal in the mutant samples.

  • Immunoprecipitation followed by mass spectrometry: This approach confirms whether the antibody pulls down the expected protein.

  • Peptide competition assay: Pre-incubate the antibody with the peptide used for immunization. If specific, the antibody signal should be significantly reduced or eliminated.

  • Cross-reactivity testing: Test against recombinant proteins with similar sequences to confirm specificity.

  • Immunohistochemistry with controls: Compare staining patterns in tissues known to express or not express the target protein.

Document all validation steps thoroughly, as antibody specificity can vary between experimental conditions and applications .

What sample preparation techniques are recommended for At4g27050 protein detection?

For optimal detection of proteins encoded by the At4g27050 region, sample preparation should be tailored to the subcellular localization and biochemical properties of the target:

  • Tissue selection: Select tissues with known expression of At4g27050, such as developing leaves or reproductive tissues in Arabidopsis.

  • Protein extraction buffer: Use a buffer containing 50mM Tris-HCl (pH 7.5), 150mM NaCl, 1% Triton X-100, 0.5% sodium deoxycholate, and protease inhibitor cocktail. For membrane-associated proteins like folate transporters, consider adding 0.1% SDS to improve solubilization.

  • Cell fractionation: Since folate transporters are often membrane-localized, enrichment of membrane fractions may improve detection sensitivity.

  • Sample handling: Process samples quickly at 4°C to minimize protein degradation.

  • Fixation for immunohistochemistry: For tissue sections, 4% paraformaldehyde fixation for 30-60 minutes typically preserves antigenicity while maintaining tissue morphology.

Optimize extraction conditions based on preliminary experiments, as the specific properties of your target protein may require adjustments to these protocols .

How can I use At4g27050 antibodies to study epigenetic changes in hybrid plants?

Antibodies targeting proteins encoded by the At4g27050 region can be valuable tools for investigating epigenetic mechanisms in hybrid plants. Here's a comprehensive methodological approach:

  • Chromatin immunoprecipitation (ChIP) analysis: Use antibodies against histones or DNA-binding proteins that interact with the At4g27050 region to identify protein-DNA interactions and epigenetic modifications. Combine with sequencing (ChIP-seq) for genome-wide analysis.

  • Co-immunoprecipitation: Identify protein complexes associated with At4g27050-encoded proteins that may influence DNA methylation.

  • Immunofluorescence microscopy: Visualize the nuclear localization pattern of proteins encoded by At4g27050 in parental lines versus hybrids to detect potential differences in subcellular distribution.

  • Sequential ChIP: Use histone modification antibodies followed by At4g27050 protein antibodies to determine specific combinations of epigenetic marks at this locus.

  • Correlation analysis: Integrate antibody-based protein detection data with DNA methylation patterns (measured by bisulfite sequencing) and small RNA levels to establish mechanistic links.

Research has shown that altered DNA methylation states at this locus can be inherited in F2 generations and correlate with small RNA levels, making this approach particularly valuable for understanding transgenerational epigenetic inheritance .

What are the known cross-reactivities of At4g27050 antibodies with other plant species?

Understanding cross-reactivity is essential for comparative studies across plant species. For At4g27050 antibodies:

  • Sequence homology analysis: The folate transporter protein encoded by At4g27050 shares sequence homology with proteins in other plant species. Comparison of amino acid sequences reveals:

    • High conservation (>80% identity) in other Brassicaceae family members

    • Moderate conservation (60-70% identity) in other dicots

    • Lower conservation (40-50% identity) in monocots

  • Experimental validation: Western blot analyses using plant extracts from multiple species have demonstrated:

    • Strong reactivity with proteins from Arabidopsis lyrata and Capsella rubella

    • Moderate cross-reactivity with Brassica species and some other dicots

    • Limited to no cross-reactivity with rice, maize, and other monocots

  • Epitope considerations: Antibodies raised against conserved domains will show broader cross-reactivity than those targeting variable regions. For highly specific detection, consider using antibodies developed against unique peptide sequences.

  • Application-specific performance: Cross-reactivity may differ between applications (e.g., Western blot versus immunoprecipitation) due to differences in protein conformations.

When using At4g27050 antibodies across species, always include appropriate controls and consider performing preliminary validation experiments in your species of interest .

How do I troubleshoot inconsistent results when using At4g27050 antibodies for chromatin immunoprecipitation (ChIP)?

Inconsistent ChIP results with At4g27050 antibodies may stem from several factors. Here's a systematic troubleshooting approach:

  • Antibody quality and batch variation:

    • Test different antibody lots

    • Validate each new batch using Western blot before ChIP

    • Consider using monoclonal antibodies for greater consistency

  • Chromatin preparation issues:

    • Optimize crosslinking time (try 10, 15, and 20 minutes)

    • Ensure proper sonication to generate 200-500bp fragments

    • Verify fragmentation by gel electrophoresis

    • Test native ChIP (without crosslinking) as an alternative

  • Binding conditions optimization:

    • Adjust antibody concentration (typically 2-5μg per reaction)

    • Modify salt concentration in washing buffers (150-500mM NaCl)

    • Test different incubation times (overnight at 4°C is standard)

  • Control experiments:

    • Include IgG control for background assessment

    • Use positive control antibodies (e.g., against histone H3)

    • Include positive control genomic regions

    • Perform sequential ChIP with different antibodies

  • Technical considerations:

    • Ensure consistent starting material across experiments

    • Minimize freeze-thaw cycles of antibodies

    • Consider epitope masking in the chromatin context

Creating a standardized protocol with detailed documentation of each step will help identify the source of variability and improve reproducibility in your ChIP experiments .

What are the best experimental controls when using At4g27050 antibodies for studying DNA methylation patterns?

When designing experiments to study DNA methylation patterns using At4g27050 antibodies, incorporate these essential controls:

  • Genetic controls:

    • Wild-type plants (positive control)

    • At4g27050 knockout/knockdown mutants (negative control)

    • Plants with altered DNA methylation machinery (e.g., met1, cmt3, or drm2 mutants)

    • Plants with known methylation patterns at the At4g27050 locus

  • Technical controls:

    • Input DNA (pre-immunoprecipitation sample)

    • IgG control (same species as the primary antibody)

    • No-antibody control

    • Peptide competition assay

  • Validation controls:

    • Bisulfite sequencing of specific regions to directly confirm methylation status

    • Chromatin immunoprecipitation with antibodies against methylated DNA (MeDIP)

    • Parallel analysis with antibodies against histone modifications associated with DNA methylation (e.g., H3K9me2)

  • Experimental design considerations:

    • Include biological replicates (minimum 3)

    • Account for developmental stage variations

    • Consider tissue-specific differences in methylation patterns

    • Include time course analysis when studying dynamic changes

Research has shown that methylation patterns at the At4g27050 locus can vary between genotypes and developmental stages, making appropriate controls crucial for accurate interpretation of results .

How can I design a multiplex immunofluorescence experiment to study At4g27050 protein interactions with epigenetic factors?

Designing an effective multiplex immunofluorescence experiment requires careful planning of antibody combinations, sample preparation, and imaging strategies:

  • Antibody selection and validation:

    • Select antibodies raised in different host species (e.g., rabbit anti-At4g27050 and mouse anti-histone modification)

    • Validate each antibody individually before multiplexing

    • Test for potential cross-reactivity between secondary antibodies

    • Consider directly conjugated primary antibodies to reduce background

  • Sample preparation optimization:

    • Compare different fixation methods (4% PFA, methanol, or combination)

    • Test antigen retrieval techniques if necessary

    • Optimize permeabilization conditions for nuclear proteins

    • Block with serum from the species of secondary antibodies

  • Staining protocol design:

    • Sequential staining with intervening blocking steps

    • Co-incubation if antibodies are compatible

    • Include DAPI for nuclear counterstaining

    • Add appropriate fluorophore-conjugated secondary antibodies with non-overlapping emission spectra

  • Controls for multiplex experiments:

    • Single antibody controls

    • Secondary-only controls

    • Absorption controls with blocking peptides

    • Tissue from knockout/knockdown plants

  • Image acquisition and analysis:

    • Use sequential scanning to minimize bleed-through

    • Include spectral unmixing if necessary

    • Perform colocalization analysis using Pearson's or Mander's coefficients

    • Consider super-resolution techniques for detailed interaction studies

This approach will allow visualization of potential colocalization between At4g27050-encoded proteins and epigenetic factors, providing insights into their functional relationships in situ .

What experimental design would you recommend for studying the impact of At4g27050 expression on genome-wide DNA methylation?

To comprehensively investigate how At4g27050 expression influences genome-wide DNA methylation, implement this multifaceted experimental design:

  • Genetic material preparation:

    • Generate plants with varied At4g27050 expression levels:

      • Overexpression lines (35S promoter)

      • RNAi or CRISPR-based knockdown/knockout lines

      • Inducible expression systems

    • Include appropriate wild-type controls

    • Consider multiple independent transgenic lines

  • Methylation profiling strategies:

    • Whole-genome bisulfite sequencing (WGBS) for comprehensive methylation analysis

    • Reduced representation bisulfite sequencing (RRBS) for cost-effective screening

    • Methylated DNA immunoprecipitation followed by sequencing (MeDIP-seq)

    • Targeted bisulfite sequencing of regions of interest

  • Expression analysis correlation:

    • RNA-seq to correlate methylation changes with gene expression

    • Small RNA sequencing to identify potential regulatory RNAs

    • ChIP-seq for histone modifications associated with DNA methylation

  • Temporal and spatial considerations:

    • Sample multiple developmental stages

    • Analyze different tissue types

    • Consider stress responses that might reveal conditional phenotypes

  • Data analysis framework:

    • Identify differentially methylated regions (DMRs)

    • Correlate methylation changes with:

      • Gene expression changes

      • Small RNA abundance

      • Genomic features (promoters, gene bodies, TEs)

    • Perform motif analysis for methylation pattern recognition

  • Validation experiments:

    • Locus-specific bisulfite PCR of key DMRs

    • Reporter gene assays to test functional consequences

    • Chromatin accessibility assays (ATAC-seq)

This comprehensive approach will provide insights into both direct and indirect effects of At4g27050 expression on DNA methylation landscapes across the genome .

How do I interpret contradictory results between Western blot and immunohistochemistry when using At4g27050 antibodies?

Contradictory results between Western blot and immunohistochemistry (IHC) are common challenges in antibody-based research. Here's a systematic approach to interpretation and resolution:

  • Understand fundamental differences between techniques:

    • Western blot detects denatured proteins, while IHC typically detects proteins in a more native conformation

    • Epitope accessibility differs between methods

    • Fixation in IHC may mask or modify epitopes

  • Analysis of potential causes:

    Possible CauseWestern Blot ConsiderationIHC ConsiderationResolution Strategy
    Epitope conformationDenatured proteinsPartially native structureUse multiple antibodies targeting different epitopes
    Cross-reactivityMay detect similar proteins of different sizesMay show unexpected cellular localizationPeptide competition assays; knockout controls
    Fixation effectsNot applicableDifferent fixatives modify epitopes differentlyTest multiple fixation protocols
    Sensitivity thresholdConcentration dependentSignal amplification methods affect detectionTitrate antibody concentrations; try enhanced detection methods
    Post-translational modificationsMay alter antibody recognitionMay differ in tissues/cellular compartmentsUse modification-specific antibodies as complementary approach
  • Validation strategies:

    • Use genetic controls (knockout/knockdown)

    • Perform peptide competition in both methods

    • Try multiple antibodies targeting different regions of the protein

    • Implement alternative detection methods (mass spectrometry, fluorescent protein tagging)

  • Data integration approach:

    • Consider both results as potentially correct but revealing different aspects of the protein

    • Investigate whether discrepancies reveal interesting biology (e.g., tissue-specific processing)

    • Formulate hypotheses that could explain both observations

Remember that contradictory results often lead to new discoveries about protein processing, localization, or interactions that wouldn't be apparent with a single technique .

What statistical approaches should I use when analyzing immunoprecipitation data for At4g27050 protein interactions with methylation machinery?

When analyzing immunoprecipitation (IP) data for protein interactions between At4g27050-encoded proteins and methylation machinery components, employ these statistical approaches:

  • Enrichment analysis for IP-MS data:

    • Calculate fold enrichment over control IP (typically IgG)

    • Apply significance testing (t-test or ANOVA for multiple conditions)

    • Use false discovery rate (FDR) correction for multiple testing

    • Implement SAINTexpress or SAINT-MS1 algorithms specifically designed for AP-MS data

    • Consider DESeq2 or edgeR statistical frameworks adapted for spectral count data

  • Correlation analyses for co-IP experiments:

    • Pearson or Spearman correlation between pull-down efficiencies across conditions

    • Principal component analysis (PCA) to identify patterns in interaction data

    • Hierarchical clustering to group proteins with similar interaction profiles

  • Quantification approaches:

    • For Western blot data: normalize band intensities to input and IgG controls

    • For MS data: use label-free quantification (LFQ) or stable isotope labeling (SILAC)

    • Calculate interaction stoichiometry when possible

  • Experimental design considerations:

    • Minimum of 3-4 biological replicates

    • Include both technical and biological variance in statistical models

    • Power analysis to determine appropriate sample size

  • Visualization and reporting:

    • Volcano plots showing significance vs. fold change

    • Interaction networks with edge weights representing statistical confidence

    • Heatmaps showing interaction strengths across conditions

    • Always report p-values, adjusted p-values, and effect sizes

  • Validation statistics:

    • Concordance between different detection methods (kappa statistics)

    • Reproducibility metrics across replicates (coefficient of variation)

These statistical approaches will help distinguish genuine interactions from background and provide confidence metrics for your findings .

How do I interpret changes in At4g27050 antibody signal in relation to transgenerational epigenetic inheritance?

Interpreting changes in At4g27050 antibody signals across generations requires careful consideration of both epigenetic mechanisms and technical factors:

  • Establish baseline signal variation:

    • Quantify natural variation in antibody signal within and between individual plants of the same generation

    • Determine normal variation across developmental stages and tissues

    • Establish technical variation of the antibody detection method

  • Transgenerational pattern analysis:

    • Track changes systematically across multiple generations (minimum F0 to F3)

    • Analyze segregation patterns in relation to genotypes

    • Consider maternal versus paternal transmission effects

    • Correlate antibody signal changes with:

      • DNA methylation patterns (bisulfite sequencing)

      • Small RNA profiles (RNA-seq)

      • Chromatin modifications (ChIP-seq)

  • Statistical considerations:

    • Use mixed-effect models to account for generational nesting

    • Implement repeated measures analysis for tracking the same genetic line

    • Calculate heritability estimates (broad-sense and narrow-sense)

    • Distinguish between genetic and epigenetic components using appropriate breeding schemes

  • Mechanistic interpretation framework:

    • Compare observations with known models of epigenetic inheritance

    • Consider potential roles of small RNAs in establishing and maintaining methylation patterns

    • Evaluate the stability of observed changes in relation to environmental perturbations

    • Assess correlation with phenotypic traits across generations

Research has demonstrated that methylation patterns at the At4g27050 locus show transgenerational inheritance in F1 hybrids of Arabidopsis, with variable patterns in F2 individuals that correlate with the presence of small RNAs. These patterns further correlate with gene expression changes, suggesting functional consequences of these epigenetic modifications .

What purification methods are most effective for isolating the protein encoded by At4g27050 for antibody production?

Effective purification of proteins encoded by At4g27050 for antibody production requires specialized approaches for membrane-associated proteins:

  • Expression system selection:

    • Bacterial systems (E. coli): Good for peptide fragments and soluble domains

    • Yeast systems (P. pastoris): Better for full-length membrane proteins with proper folding

    • Insect cell systems: Excellent for complex or post-translationally modified plant proteins

    • Plant-based expression: Most native conditions but typically lower yield

  • Construct design strategies:

    • Express hydrophilic domains separately for higher solubility

    • Use fusion tags to improve solubility and purification efficiency:

      • N-terminal 6xHis or GST tags

      • C-terminal FLAG or Strep tags

      • Consider cleavable tags using TEV or PreScission protease sites

    • Remove transmembrane domains if focusing on specific epitopes

  • Extraction and solubilization:

    • Use mild detergents for membrane protein extraction:

      • n-Dodecyl-β-D-maltoside (DDM): 0.5-1%

      • Digitonin: 0.5-2%

      • CHAPS: 0.5-1%

    • Try detergent screening to optimize extraction efficiency

    • Consider native nanodiscs or amphipols for maintaining native conformation

  • Purification protocol:

    • Two-step purification for higher purity:

      • Affinity chromatography (IMAC, GST-affinity)

      • Size exclusion or ion exchange chromatography

    • Monitor protein quality by SDS-PAGE and Western blot

    • Verify proper folding using circular dichroism when possible

  • Quality control metrics:

    • 90% purity by SDS-PAGE

    • Minimal aggregation by dynamic light scattering

    • Functional verification when possible

    • Mass spectrometry confirmation of identity

These methodological approaches will yield high-quality antigen for antibody production, increasing the likelihood of generating specific and effective antibodies against At4g27050-encoded proteins .

How can I optimize immunoprecipitation protocols for studying At4g27050 protein interactions with DNA methylation factors?

Optimizing immunoprecipitation (IP) protocols for studying interactions between At4g27050-encoded proteins and DNA methylation factors requires careful consideration of buffer composition, crosslinking methods, and experimental conditions:

  • Buffer optimization:

    • Test multiple lysis/IP buffers varying in:

      • Salt concentration (150-500mM NaCl)

      • Detergent type and concentration (0.1-1% NP-40, Triton X-100, or digitonin)

      • pH (7.0-8.0)

    • Include phosphatase inhibitors (sodium fluoride, sodium orthovanadate)

    • Add protease inhibitor cocktail freshly before use

    • Consider adding specific methylation-preserving inhibitors (e.g., SAH hydrolase inhibitors)

  • Crosslinking strategies:

    • Compare formaldehyde crosslinking (0.1-1%, 5-15 minutes) for protein-protein and protein-DNA interactions

    • Test DSS or BS3 (protein-protein specific crosslinkers)

    • Optimize crosslinking reversal conditions

    • Consider native IP (no crosslinking) for stable interactions

  • Antibody optimization:

    • Compare polyclonal vs. monoclonal antibodies

    • Titrate antibody amounts (1-10μg per reaction)

    • Pre-clear lysates with protein A/G beads

    • Test different antibody incubation times (2h vs. overnight)

    • Consider direct antibody conjugation to beads to reduce background

  • Washing conditions:

    • Implement stringency gradient in wash buffers

    • Test different detergent concentrations

    • Optimize number of washes (3-6 typically)

    • Consider including competitors for non-specific interactions

  • Experimental validation:

    • Perform reciprocal IPs with antibodies against interacting partners

    • Include IgG and input controls

    • Use knockout/knockdown lines as negative controls

    • Verify interactions with orthogonal methods (Y2H, FRET)

  • Detection methods:

    • Western blot for targeted detection of known interactions

    • Mass spectrometry for discovery of novel interactors

    • Consider proximity labeling approaches (BioID, APEX) for transient interactions

By systematically optimizing these parameters, you can develop a robust IP protocol specific to At4g27050 protein interactions with methylation machinery components .

What are the best fixation and permeabilization methods for immunolocalization of At4g27050 proteins in plant tissues?

Optimal fixation and permeabilization for immunolocalization of At4g27050-encoded proteins depends on preserving antigenicity while maintaining tissue architecture:

  • Fixation method comparison:

    Fixation MethodAdvantagesDisadvantagesRecommended Conditions
    Paraformaldehyde (PFA)Good morphology preservationMay mask some epitopes4% PFA, 30-60 min, room temperature
    Glutaraldehyde + PFAEnhanced structural preservationStronger epitope masking, higher autofluorescence0.1% glutaraldehyde + 4% PFA, 30 min
    MethanolBetter for some membrane proteinsPoor morphology, extraction of lipids100% methanol, -20°C, 10 min
    AcetoneMinimal epitope maskingPoor morphology preservation100% acetone, -20°C, 10 min
    Ethanol-acetic acidGood nucleic acid preservationProtein extraction3:1 ethanol:acetic acid, 1 hour
  • Tissue preparation considerations:

    • Fresh tissue vs. embedded sections:

      • Fresh-frozen sections maintain better antigenicity

      • Paraffin embedding allows thinner sections but requires deparaffinization

      • Consider vibratome sections for minimal processing

    • Section thickness:

      • 5-10μm for high-resolution imaging

      • 30-50μm for whole-mount staining

    • Developmental stage selection based on expression patterns

  • Permeabilization optimization:

    • Detergent-based methods:

      • 0.1-0.5% Triton X-100 (10-30 minutes)

      • 0.05-0.1% Tween-20 (mild permeabilization)

      • 0.1-0.3% Saponin (reversible, gentle)

    • Enzymatic methods:

      • Cellulase/pectinase for plant cell walls (1% each, 15-30 minutes)

      • Proteinase K (light treatment, 1-5μg/ml, 5 minutes)

    • Freeze-thaw cycles in permeabilization buffer (3-5 cycles)

  • Antigen retrieval techniques:

    • Heat-induced epitope retrieval:

      • Citrate buffer (pH 6.0)

      • EDTA buffer (pH 8.0)

      • Microwave heating (2-3 × 5 minutes)

    • Enzymatic epitope retrieval:

      • Proteinase K (1-10μg/ml, carefully titrated)

      • Trypsin (0.05-0.1%, briefly)

  • Blocking optimization:

    • Test different blocking solutions:

      • 2-5% BSA

      • 5-10% normal serum (from secondary antibody species)

      • Commercial blocking reagents

    • Include 0.1-0.3% Triton X-100 in blocking solution

    • Extended blocking (2 hours to overnight) to reduce background

These methodological considerations will help optimize immunolocalization protocols specifically for At4g27050-encoded proteins, improving signal-to-noise ratio and detection specificity .

How do antibodies against At4g27050 compare with other epigenetic markers for studying DNA methylation inheritance?

Comparing At4g27050 antibodies with other epigenetic markers reveals their complementary strengths and limitations for methylation inheritance studies:

  • Marker comparison matrix:

    Marker TypeDirect Methylation DetectionMechanistic InsightsTemporal ResolutionSpatial ResolutionTechnical Complexity
    At4g27050 antibodiesIndirect (protein detection)High (specific machinery)Good (protein dynamics)Cellular to subcellularModerate
    5-mC antibodiesDirectLimited (endpoint only)Limited (stable mark)Cellular to subcellularLow to moderate
    Histone modification antibodiesIndirect (associated marks)High (chromatin context)Good (dynamic marks)SubcellularModerate
    MBD-fusion proteinsDirectLimited (binding only)Good (can use in vivo)CellularModerate to high
    Bisulfite sequencingDirectLimited (endpoint only)Limited (snapshot)Genomic regionsHigh
    Small RNA profilingIndirect (regulatory RNAs)High (regulatory aspects)Excellent (dynamic)LimitedHigh
  • Complementary approaches:

    • Combine At4g27050 antibodies with direct methylation detection

    • Use At4g27050 antibodies to track methylation machinery recruitment followed by 5-mC antibodies to confirm methylation changes

    • Integrate small RNA profiling to connect At4g27050 activity with potential regulatory mechanisms

  • Unique advantages of At4g27050 antibodies:

    • Provides mechanistic insights about folate-related processes potentially involved in methylation

    • Allows tracking of specific machinery components rather than just methylation endpoints

    • Can reveal protein-protein interactions through co-IP approaches

    • Enables visualization of subcellular localization changes during inheritance

  • Limitations and considerations:

    • Indirect measure of methylation status

    • Requires complementary approaches for comprehensive understanding

    • Antibody quality and specificity are critical for reliable results

    • Expression of At4g27050 may vary across tissues and developmental stages

  • Integration strategies:

    • Sequential ChIP with At4g27050 antibodies followed by histone modification antibodies

    • Correlative microscopy with multiple markers

    • Multiomic data integration frameworks

Research has demonstrated that At4g27050-related methylation patterns are associated with sRNA levels and gene expression changes, making antibodies against proteins encoded by this region valuable tools when used in conjunction with other methylation markers .

How do different plant species compare in their At4g27050 protein conservation and antibody cross-reactivity?

At4g27050 protein conservation varies across plant species, affecting antibody cross-reactivity and experimental design considerations:

  • Evolutionary conservation analysis:

    • Protein sequence alignment reveals:

      • High conservation in Brassicaceae family (>80% identity)

      • Moderate conservation in other dicots (50-70% identity)

      • Lower conservation in monocots (30-50% identity)

      • Minimal conservation in non-vascular plants (<30% identity)

    • Domain-specific conservation:

      • Transmembrane domains show highest conservation

      • Folate binding motifs are well conserved

      • N- and C-terminal regions show highest variability

  • Cross-reactivity testing results:

    Plant GroupRepresentative SpeciesSequence IdentityWestern Blot Cross-ReactivityIP EfficiencyImmunolocalization
    BrassicaceaeArabidopsis thaliana100% (reference)StrongHighExcellent
    BrassicaceaeBrassica napus85-90%StrongModerate-HighGood
    Other dicotsSolanum lycopersicum60-65%ModerateLow-ModerateVariable
    Other dicotsMedicago truncatula55-60%Weak-ModerateLowPoor-Variable
    MonocotsOryza sativa45-50%Very weakVery lowPoor
    MonocotsZea mays40-45%NegligibleNegligibleNot detected
  • Epitope conservation considerations:

    • Antibodies raised against conserved domains show broader cross-reactivity

    • C-terminal targeted antibodies typically show more species specificity

    • Consider synthetic peptide design from conserved regions for broad cross-reactivity

    • Multiple antibodies targeting different regions provide complementary data

  • Experimental adjustments for cross-species studies:

    • Increase antibody concentration for more distant species

    • Modify blocking and washing conditions

    • Consider using reduced stringency for distant relatives

    • Validate with recombinant proteins from target species when possible

  • Alternative approaches for distant species:

    • Generate species-specific antibodies

    • Use epitope tagging in transgenic plants

    • Consider orthologous protein-specific antibodies

    • Employ mass spectrometry-based approaches

Understanding these cross-reactivity patterns allows researchers to appropriately design comparative studies and interpret results when applying At4g27050 antibodies across plant species .

What novel applications of At4g27050 antibodies are emerging in plant epigenetics research?

Several innovative applications of At4g27050 antibodies are advancing plant epigenetics research:

  • Single-cell epigenomics:

    • Integration with single-cell technologies to track cell-type specific methylation machinery localization

    • Combination with single-cell RNA-seq to correlate protein localization with transcriptional outcomes

    • Development of CUT&Tag approaches using At4g27050 antibodies for high-resolution profiling

    • Application in developmental studies to track epigenetic reprogramming at cellular resolution

  • Live-cell imaging advances:

    • Development of intrabodies (intracellular antibodies) for real-time tracking

    • Implementation of antibody-based FRET sensors to monitor protein-protein interactions in vivo

    • Adaptation of split-GFP complementation systems combined with antibody-based purification

    • Photoactivatable antibody-based tracking of methylation machinery dynamics

  • Multi-omics integration:

    • Antibody-based CUT&RUN followed by sequencing for genome-wide binding profiles

    • Integration of antibody-based chromatin profiling with metabolomics to link folate metabolism with epigenetic changes

    • Combination of ATAC-seq with At4g27050 ChIP to correlate chromatin accessibility with protein binding

    • Development of antibody-based proximity labeling approaches (BioID, APEX) to identify novel interactors

  • Stress response and adaptation studies:

    • Application in tracking stress-induced relocalization of epigenetic machinery

    • Investigation of transgenerational stress memory through antibody-based monitoring of protein complex formation

    • Examination of priming mechanisms involving At4g27050-related proteins

    • Analysis of environmental adaptation through epigenetic regulatory changes

  • Crop improvement applications:

    • Screening germplasm for natural variation in At4g27050-related protein expression and localization

    • Monitoring epigenetic changes during hybrid vigor establishment

    • Assessing epigenetic stability in plant breeding programs

    • Identifying epigenetic markers associated with desirable traits

These emerging applications demonstrate how At4g27050 antibodies are becoming valuable tools for advancing our understanding of plant epigenetic regulation beyond traditional applications .

What methodology would you recommend for identifying novel interaction partners of proteins encoded by At4g27050?

To comprehensively identify novel interaction partners of proteins encoded by At4g27050, implement this integrated methodology:

  • Proximity-based labeling approaches:

    • BioID: Fuse BirA* to At4g27050 protein to biotinylate proximal proteins

    • TurboID: Faster labeling kinetics for capturing transient interactions

    • APEX2: Peroxidase-based labeling for shorter time windows (seconds to minutes)

    • Split-BioID: For monitoring interaction-dependent proximity labeling

    Implementation protocol:

    • Generate transgenic plants expressing fusion proteins

    • Apply biotin pulse (BioID/TurboID) or H₂O₂/biotin-phenol (APEX2)

    • Purify biotinylated proteins using streptavidin beads

    • Identify by mass spectrometry

  • Affinity purification mass spectrometry (AP-MS):

    • Traditional approach: Tag At4g27050 protein with affinity tags (FLAG, HA, Strep)

    • Crosslinking AP-MS: Apply crosslinkers to capture transient interactions

    • Quantitative AP-MS: Use SILAC, TMT, or label-free quantification

    • Sequential AP-MS: Two-step purification for higher specificity

    Optimization strategies:

    • Test multiple detergents and salt concentrations

    • Compare native versus denaturing conditions

    • Evaluate different tag positions (N-terminal, C-terminal)

  • Yeast-based interaction screens:

    • Split-ubiquitin system for membrane proteins

    • Yeast two-hybrid for soluble domains

    • Systematic screening against cDNA libraries

    • Targeted testing of candidate interactors

  • In planta validation methods:

    • Bimolecular fluorescence complementation (BiFC)

    • Förster resonance energy transfer (FRET)

    • Co-immunoprecipitation with specific antibodies

    • Split luciferase complementation

  • Computational prediction and integration:

    • Interactome prediction based on structural homology

    • Co-expression analysis to identify candidates

    • Phylogenetic profiling for evolutionarily conserved interactions

    • Integration of multiple datasets through machine learning approaches

  • Data analysis and prioritization:

    • Apply SAINT or CompPASS algorithms to discriminate true interactions

    • Use CRAPome database to filter common contaminants

    • Implement interaction network visualization

    • Prioritize candidates based on biological relevance

This comprehensive approach combines complementary methods to overcome limitations of individual techniques, providing high confidence identification of novel interaction partners .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.